Search clinical trials for: Elacytarabine plus idarubicin

Total 5003 results

Clavis Pharma
Syneos Health; Theradex

Completed

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Acute Myeloid Leukemia

United States, Norway, Germany, France
Clavis Pharma
Syneos Health; Theradex; CardiaBase; Learn & Confirm

Completed

The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055)

Relapsed/Refractory AML

United Kingdom, Spain
Clavis Pharma

Completed

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) (CLAVELA)

Acute Myeloid Leukemia (AML)

United States, Spain, France, Ireland, United Kingdom, Australia, Belgium, Canada, Germany, Italy, Norway, Poland, Romania
The First Affiliated Hospital of Soochow University
Second Affiliated Hospital of Soochow University; The Second People's Hospital... and other collaborators

Unknown

Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients

Acute Myeloid Leukemia | Induction Chemotherapy

China
Clavis Pharma

Completed

Elacytarabine Mass Balance Study in Healthy Volunteers

Not Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy Subjects

United Kingdom
Cancer Institute and Hospital, Chinese Academy...

Unknown

Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia

Childhood Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | Philadelphia Chromosome, Ph^1^, Absent

China
PETHEMA Foundation

Recruiting

PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years

Acute Myeloblastic Leukemia

Spain
Cooperative Study Group A for Hematology

Unknown

Idarubicin Versus High Dose Daunorubicin in Acute Myelogenous Leukemia (AML) (AIvsAD)

Acute Myelogenous Leukemia

Korea, Republic of
Children's Hospital of Soochow University

Recruiting

Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation

AML, Childhood | C-KIT Mutation | Refractory AML | Relapse/Recurrence | Core Binding Factor Acute Myeloid Leukemia

China
RenJi Hospital
Shanghai Pudong Hospital; Shanghai Pudong New Area Gongli Hospital

Unknown

Single Versus Long-term Intravesical Instillation Chemotherapy for Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma

Intravesical Instillation

China
The Affiliated Hospital of the Chinese Academy...

Unknown

HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
Zhongda Hospital

Recruiting

Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
University Hospital, Montpellier
Guerbet

Recruiting

Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion (LIDA-BII)

Carcinoma, Hepatocellular

France
Federation Francophone de Cancerologie Digestive

Completed

Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II (IDASPHERE II)

Liver Cancer

France
Lahey Clinic

Completed

Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion

Dry Eye Syndrome

United States
University Hospital, Montpellier

Completed

TACE for HCC by TANDEM and Idarubicin (TANDEM-IDA)

Hepatocellular Carcinoma (HCC)

France
Groupe Francophone des Myelodysplasies

Completed

Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes

High Grade Myelodysplastic Syndrome Lesions

France, Tunisia
Centre Hospitalier Universitaire Dijon

Completed

Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas

Carcinoma, Hepatocellular

France
MedImmune LLC

Completed

Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia | Leukemia

United States, Israel
Acute Leukemia French Association
Assistance Publique - Hôpitaux de Paris

Terminated

A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.

Acute Myeloid Leukemia

France
Onxeo

Completed

Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive Therapy

Acute Myeloid Leukemia

United Kingdom, Germany, France
Poitiers University Hospital

Completed

Phase I/II Study of Escalating Doses of Idarubicin Orally Given With Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patient With Disseminated High Grade Non Hodgkin Lymphoma

High Grade Lymphomas CD20 Positive

France
Guangdong Provincial People's Hospital

Unknown

Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia

Acute Myeloid Leukemia
Qure Healthcare, LLC
Lineagen

Completed

Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study

Intellectual Disability | Developmental Delay

United States
University of South Carolina
American Cancer Society, Inc.

Completed

Peers Promoting Exercise Adoption and Maintenance Among Cancer Survivors

Breast Cancer

United States
University Hospital, Montpellier

Withdrawn

The Impact on Hepatic Recurrence After Adjuvant Chemotherapy With Intraarterial Infusion of Idarubicin-Lipiodol (LIDA-ADJ)

Hepatocellular Carcinoma

France
Zhejiang Cancer Hospital

Not yet recruiting

Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Cephalon

Terminated

Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia

Leukemia

United States
The University of Tennessee, Knoxville
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Cherokee...

Completed

Implementing Prevention Plus for Childhood Overweight and Obesity in Food Secure and Insecure Families

Obesity | Childhood Obesity

United States
ResMed

Completed

Evaluation of ApneaLink Plus Scoring Capabilities

Sleep Apnea, Obstructive | Sleep Apnea, Central

Germany
Peking University First Hospital

Unknown

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients

Upper Tract Urothelial Carcinoma | Bladder Recurrence

China
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Leukemia

United States
Alma Lasers Inc.

Unknown

Epidermal Delivery of Ani-Aging Ingredients

Acne Scars | Wrinkles | Pigmentation

United States
Ethicon, Inc.

Completed

A Study of Two Types of Absorbable Surgical Sutures in the Suturing of Thyroid Surgery Incision (Nautilus)

Sutures

China
Farmaceutici Damor Spa

Recruiting

Effectiveness and Tolerability of Fitostimoline Plus Cream and Gauze vs Connettivina Bio Plus Cream and Gauze (FP)

Wounds and Injuries | Wound Infection | Wound Heal

Italy
University of Trier
German Research Foundation

Completed

Randomized Controlled Trial to Evaluate Personalized Prediction and Adaptation Tools in Psychotherapy

Feedback, Psychological

Germany
Lahore General Hospital

Unknown

Remdesivir in COVID-19 Lahore General Hospital (RC19LGH)

SARS-CoV Infection

Pakistan
Peking University First Hospital

Unknown

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients

Upper Tract Urothelial Carcinoma | Bladder Recurrence | Nephroureterectomy

China
Peking Union Medical College Hospital

Recruiting

IA14 Induction in Young Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
Eli Lilly and Company

Completed

A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
Vanderbilt University Medical Center

Recruiting

BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity (BRAVE)

Breast Cancer

United States
Zhejiang Cancer Hospital

Recruiting

Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct Adenocarcinoma

Bile Duct Adenocarcinoma

China
Hospital General Universitario Gregorio Marañon
Instituto de Salud Carlos III

Completed

Use of a Pressurized Face Mask for Preventing Respiratory Complications After Chest Surgery

Lung Resection

Spain
National Institute of Diabetes and Digestive and...

Completed

Physical Activity in the Treatment of Obesity (CHANGE)

Obesity

United States
NuVasive

Completed

Osteocel® Plus in eXtreme Lateral Interbody Fusion (XLIF®)

Back Pain | Degenerative Disc Disease

United States
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...

Completed

Synergic Effects of Ultrasound and Laser on the Pain Relief and Functionality

Osteoarthritis

Brazil
Azienda Sanitaria Locale Napoli 2 Nord

Recruiting

ProSpectic Italian Laparoscopic Hybrid mEsh hErnia Repair in Obese patientS Trials (PSICHE-EROS)

Obesity | Uncomplicated Ventral Incisional Hernia

Italy
Parc de Salut Mar

Completed

Self-screening of Cardiovascular Risk (ACRISC)

Risk Factor, Cardiovascular

Spain
Bayside Health
The Alfred; The Leukaemia Foundation of Victoria

Unknown

RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMT

Hematological Malignancies

Australia
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia

Leukemia

United States

Search clinical trials for: Elacytarabine plus idarubicin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations